To find out more about cannabis testing in California and how CannaSafe is working hard to ensure consumers and patients receive contaminant-free and rigorously-tested cannabis, we spoke to their President, Aaron Riley.Read More
Without a doubt, we will remember 2020 as the year of the COVID-19 pandemic. For the biopharma and healthcare sectors, the focus was firmly on the rapid development of diagnostics, therapies and vaccines that could be produced at scale. But under the radar, other life science fields have been powering on – among them, the cardiac field.Read More
In this interview, Dr Kaveh Kahen, Senior Director and General Manager of Mass Spectrometry for PerkinElmer, gives his view on technical challenges in cannabis testing and how they can help labs in this growing industry.
Driven by the introduction and evolution of cannabis contaminant testing, and regulations in many different states, companies in the cannabis testing industry are constantly innovating and creating new methods and applications for use in testing laboratories. We spoke to Anthony Macherone to learn more about some of the major trends and potential future themes in the cannabis testing industry.Read More
The therapeutic effects of the psychedelic compound psilocybin, derived from so-called “magic mushrooms” such as Psilocybe semilanceata, are now being more widely understood by medical science. New efforts are trying to tease out what would be a minimal effective dose of psilocybin, one that would have beneficial effects on the brain whilst minimizing hallucinatory experiences. Technology Networks talked to Steven Sadoff of Canadian company Sansero Life Sciences to find out more.Read More
Liquid chromatography (LC) is an essential technique is many analytical labs. Dr Bob Pirok and his team use informatics techniques to make LC more automated and pain-free. Technology Networks recently spoke to Pirok to find out more about his innovative algorithms.Read More
Single-cell technologies have positioned themselves at the forefront of biomedical research. But the value of these systems risks being impaired by bottlenecks in data analysis and handling. To find out more, we spoke to Marilyn Matz, CEO and co-founder of Paradigm4.Read More
SynDevRx is working to address the unmet medical need in the field of metabo-oncology by developing treatments for cancer patients who are overweight or have systemic metabolic dysfunction. Technology Networks recently spoke with SynDevRx's Jim Shanahan, to explore the impact of metabolic dysfunction on treatment outcomes and learn more about the company’s lead compound SDX-7320.Read More
The clinical trials industry, like many other global sectors, has been hit hard by the pandemic. One outcome has been the necessary diversion of resources to the development of COVID-19 vaccines and treatments alongside the care of critically ill patients. Impending economic contraction around the world means trials are also taking place against a backdrop of tighter budgets, leaving clinical development on a cliff edge as 2021 approaches.
With demands for food rising as the population continues to expand, and the ever-present threat of climate change, scientists are looking for innovative ways to feed society without adding to the planet’s burdens. Plant-based foods are one area of great interest to meet this need.Read More